17-63918770-T-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_000515.5(GH1):āc.7A>Cā(p.Thr3Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000281 in 1,613,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T3A) has been classified as Likely benign.
Frequency
Consequence
NM_000515.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GH1 | NM_000515.5 | c.7A>C | p.Thr3Pro | missense_variant | 1/5 | ENST00000323322.10 | NP_000506.2 | |
GH1 | NM_022559.4 | c.7A>C | p.Thr3Pro | missense_variant | 1/5 | NP_072053.1 | ||
GH1 | NM_022560.4 | c.7A>C | p.Thr3Pro | missense_variant | 1/4 | NP_072054.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GH1 | ENST00000323322.10 | c.7A>C | p.Thr3Pro | missense_variant | 1/5 | 1 | NM_000515.5 | ENSP00000312673 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000394 AC: 60AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000232 AC: 58AN: 249884Hom.: 1 AF XY: 0.000222 AC XY: 30AN XY: 135138
GnomAD4 exome AF: 0.000269 AC: 393AN: 1460778Hom.: 0 Cov.: 35 AF XY: 0.000263 AC XY: 191AN XY: 726758
GnomAD4 genome AF: 0.000394 AC: 60AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74478
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 23, 2018 | The T3P variant in the GH1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. This variant is observed in 10/23,584 alleles (0.042%) from individuals of African background and 10/34,282 alleles (0.029%) from individuals of Latino background, with one homozygous control individual reported, in the gnomAD dataset (Lek et al., 2016). The T3P variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position that is not conserved across species, and in silico analysis predicts this variant likely does not alter the protein structure/function. We interpret T3P as a variant of uncertain significance. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 22, 2023 | Variant summary: GH1 c.7A>C (p.Thr3Pro) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00023 in 249884 control chromosomes in the gnomAD database, including 1 homozygote. The observed variant frequency is approximately 4 fold of the estimated maximal expected allele frequency for a pathogenic variant in GH1 causing Idiopathic Growth Hormone Deficiency phenotype (6.3e-05), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.7A>C in individuals affected with Idiopathic Growth Hormone Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. The following publications have been ascertained in the context of this evaluation (PMID: 17223997, 18950677). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at